Bernard Klonjkowski

Title: The Innovations of Bernard Klonjkowski

Introduction

Bernard Klonjkowski is a notable inventor based in Joinville le Pont, France. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenoviral vectors. His work has implications for therapeutic methods that utilize these vectors.

Latest Patents

Klonjkowski holds a patent for "Recombinant adenoviral vectors and applications thereof." This patent involves recombinant adenoviruses or pseudoviruses that have a deletion of all or part of the region of the adenovirus genome corresponding to nucleotides 311 to 499 in canine adenovirus type 2 (GeneBank J04368). The therapeutic methods associated with this invention focus on the use of the recombinant adenovirus or pseudovirus for medical applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Klonjkowski has worked with prestigious institutions such as the Institut National de la Recherche Agronomique (INRA) and the École Nationale Vétérinaire d'Alfort. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

One of his notable collaborators is Marc Eloit. Their partnership has likely fostered innovative ideas and advancements in their respective fields.

Conclusion

Bernard Klonjkowski's work in recombinant adenoviral vectors showcases his innovative spirit and dedication to advancing biotechnology. His contributions have the potential to impact therapeutic methods significantly.